Communicable disease threats report, 19-25 September, week 39
September 26, 2026
14-day notification rate weighted by vaccine uptake, updated 21 April 2022 (colour-blind friendly)
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
14-day notification rate weighted by vaccine uptake, updated 14 April 2022
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
14-day notification rate weighted by vaccine uptake, updated 14 April 2022 (colour-blind friendly)
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
Communicable disease threats report, 10-16 April 2022, week 15
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 April 2022 and includes updates on COVID-19, the influx of people displaced from Ukraine to the EU following Russia’s invasion of Ukraine, measles and hepatitis.
Communicable disease threats report, 3-9 April 2022, week 14
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 April 2022 and includes updates on COVID-19, the influx of people displaced from Ukraine to the EU following Russia’s invasion of Ukraine, seasonal influenza, hepatitis, monophasic Salmonella Typhimurium, MERS-CoV, chikungunya and dengue.
14-day notification rate weighted by vaccine uptake, updated 7 April 2022
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
14-day notification rate weighted by vaccine uptake, updated 7 April 2022 (colour-blind friendly)
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines
ECDC and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and Moderna’s Spikevax) in the general population.
Video: ECDC Director on fourth doses of mRNA COVID-19 vaccines
Statement by ECDC Director, Dr Andrea Ammon, on the fourth dose of the mRNA COVID-19 vaccine.
